Volume 86 Issue 40 | p. 20 | Concentrates
Issue Date: October 6, 2008

Advinus And Orchid Sign Discovery Deals

Department: Business

Two Indian firms have entered drug discovery and development agreements with Western drug companies. Advinus Therapeutics will work with Ortho-McNeil-Janssen Pharmaceuticals to develop drug candidates for various targets. Advinus says it will receive an up-front payment and possible milestone payments of up to $247 million upon successful development of two compounds. Meanwhile, Orchid Chemicals & Pharmaceuticals will work with Merck & Co. on novel agents for bacterial and fungal infections. Orchid says it will get an up-front payment and possible milestone payments of more than $100 million.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment